Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Clinical manifestations of neuromyelitis optica in male and female patients.
Reduced expression of membrane-bound (m)RAGE is a biomarker of multiple sclerosis disease progression.
Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS).
Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis.
How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register.
Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord.
Political notebook.
A rare case of multiple sclerosis and McArdle disease.
Curcumin ameliorates rat experimental autoimmune neuritis.
[Chronic inflammatory demyelinating polyradiculoneuropathy revealing essential thrombocythemia].
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
Three Minor Diterpenoids with Three Carbon Skeletons from Euphorbia peplus.
Clinical and Radiological Characteristics in Multiple Sclerosis Patients with Large Cavitary Lesions.
Country break-out session highlights.
Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
Neuroimaging biomarkers of neurodegenerative diseases and dementia.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent.
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica.
Identification of Inflammatory Neuronal Injury and Prevention of Neuronal Damage in Multiple Sclerosis: Hope for Novel Therapies?

Pages